Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gerken

Showing results (21-30 of 175) with videos related to

Pageof 18
Sort By:
The Journal of Physical Chemistry. A|June 29, 2010
Anomeric effects in sulfonyl compounds: an experimental and computational study of fluorosulfonyl azide, FSO(2)N(3), and trifluoromethylsulfonyl azide, CF(3)SO(2)N(3)Xiaoqing Zeng, Michael Gerken, Helmut Beckers, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|June 21, 2016
[The contribution of clinical cancer registries to benefit assessments: Requirements and first results]Monika Klinkhammer-Schalke, Ferdinand Hofstädter, Michael Gerken, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 21, 2023
Interaction Modes Between SF<sub>4</sub> and Ketones; Study of Intermediates in Deoxofluorination ReactionsDaniel Stuart, Felix O'Donnell, Stacey D Wetmore, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 21, 2020
Stabilisation of [WF<sub>5</sub> ]<sup>+</sup> and WF<sub>5</sub> by Pyridine: Facile Access to [WF<sub>5</sub> (NC<sub>5</sub> H<sub>5</sub> )<sub>3</sub> ]<sup>+</sup> and WF<sub>5</sub> (NC<sub>5</sub> H<sub>5</sub> )<sub>2</sub>Douglas Turnbull, Paul Hazendonk, Stacey D Wetmore, et al.
International Journal of Cancer|November 15, 2018
Reply to Lu: Connecting the dots between metformin and high-grade gliomaCorinna Seliger, Michael Gerken, Michael F Leitzmann, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|October 18, 2015
[Quality management in oncology supported by clinical cancer registries]Monika Klinkhammer-Schalke, Michael Gerken, Hagen Barlag, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 24, 2021
Donor-Stabilised [SbF<sub>4</sub> ]<sup>+</sup> : SbF<sub>5</sub> as a Fluoride-Ion DonorFelix O'Donnell, Douglas Turnbull, Stacey D Wetmore, et al.
International Journal of Colorectal Disease|August 23, 2018
Benefit of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with isolated peritoneal metastases from colorectal cancerPompiliu Piso, Kathrin Stierstorfer, Michael Gerken, et al.
Geburtshilfe Und Frauenheilkunde|September 4, 2025
Certification of a Rural Endometriosis Clinic Leads to Improvement in the Diagnosis and Treatment of Endometriosis - a Retrospective AnalysisCynthia Kohl, Jana Kager, Raul Donutiu, et al.
BMJ Open|June 18, 2024
How accurate is clinical prognostication by oncologists during routine practice in a general hospital and can it be improved by a specific prognosis training programme: a prospective interventional studyIrma Kupf, Gabriele Thanner, Michael Gerken, et al.
Pageof 18

Showing results (21-30 of 175) with videos related to

Sort By:
Pageof 18
The Journal of Physical Chemistry. A|June 29, 2010
Anomeric effects in sulfonyl compounds: an experimental and computational study of fluorosulfonyl azide, FSO(2)N(3), and trifluoromethylsulfonyl azide, CF(3)SO(2)N(3)Xiaoqing Zeng, Michael Gerken, Helmut Beckers, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|June 21, 2016
[The contribution of clinical cancer registries to benefit assessments: Requirements and first results]Monika Klinkhammer-Schalke, Ferdinand Hofstädter, Michael Gerken, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 21, 2023
Interaction Modes Between SF<sub>4</sub> and Ketones; Study of Intermediates in Deoxofluorination ReactionsDaniel Stuart, Felix O'Donnell, Stacey D Wetmore, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 21, 2020
Stabilisation of [WF<sub>5</sub> ]<sup>+</sup> and WF<sub>5</sub> by Pyridine: Facile Access to [WF<sub>5</sub> (NC<sub>5</sub> H<sub>5</sub> )<sub>3</sub> ]<sup>+</sup> and WF<sub>5</sub> (NC<sub>5</sub> H<sub>5</sub> )<sub>2</sub>Douglas Turnbull, Paul Hazendonk, Stacey D Wetmore, et al.
International Journal of Cancer|November 15, 2018
Reply to Lu: Connecting the dots between metformin and high-grade gliomaCorinna Seliger, Michael Gerken, Michael F Leitzmann, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|October 18, 2015
[Quality management in oncology supported by clinical cancer registries]Monika Klinkhammer-Schalke, Michael Gerken, Hagen Barlag, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 24, 2021
Donor-Stabilised [SbF<sub>4</sub> ]<sup>+</sup> : SbF<sub>5</sub> as a Fluoride-Ion DonorFelix O'Donnell, Douglas Turnbull, Stacey D Wetmore, et al.
International Journal of Colorectal Disease|August 23, 2018
Benefit of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with isolated peritoneal metastases from colorectal cancerPompiliu Piso, Kathrin Stierstorfer, Michael Gerken, et al.
Geburtshilfe Und Frauenheilkunde|September 4, 2025
Certification of a Rural Endometriosis Clinic Leads to Improvement in the Diagnosis and Treatment of Endometriosis - a Retrospective AnalysisCynthia Kohl, Jana Kager, Raul Donutiu, et al.
BMJ Open|June 18, 2024
How accurate is clinical prognostication by oncologists during routine practice in a general hospital and can it be improved by a specific prognosis training programme: a prospective interventional studyIrma Kupf, Gabriele Thanner, Michael Gerken, et al.
Pageof 18